Literature DB >> 12398869

Bronchiolar airflow impairment after lung transplantation: an early and common manifestation.

Jan Paul Ouwens1, Thomas W van der Mark, Gerard H Koëter, Wim J de Boer, René G Grevink, Wim van der Bij.   

Abstract

BACKGROUND: Bronchiolitis obliterans syndrome (BOS) is the major limitation to long-term survival after lung transplantation (LT). In this study we investigate the extent and frequency of airflow limitation after LT and its value for the diagnosis of BOS.
METHODS: Flow-volume measurements were analyzed retrospectively in 36 recipients of a bilateral LT, with a median follow-up of 32.9 months. The prevalence and onset of a decline of FEV(1), FEF(25), FEF(50), FEF(75) and MMEF(75/25) were evaluated and subsequently related to the occurrence of Grade 1 BOS.
RESULTS: Grade 1 BOS was diagnosed in 16 recipients at a median of 218 (range 88 to 1,007) days after LT. A persistent and significant decrease in FEV(1), FEF(25), FEF(50), FEF(75) and MMEF(75/25) was observed in 23, 24, 30, 32 and 29 patients, respectively. In those patients developing BOS during follow-up this decrease was determined at 147 (55 to 657), 130 (78 to 932), 110 (21 to 573), 103 (32 to 657) and 121 (32 to 657) days after LT (p < 0.0005), respectively. The respective predictive values of these parameters for the occurrence of Grade 1 BOS (within 120 days) were 88%, 60%, 50%, 35% and 41%.
CONCLUSION: Bronchiolar dysfunction is a common and early finding after LT. The decrease of FEV(1) in BOS is often preceded by a decrease of bronchial airflow. Airflow markers may be used as an early warning sign for the development of BOS, although their predictive values are moderate.

Entities:  

Mesh:

Year:  2002        PMID: 12398869     DOI: 10.1016/s1053-2498(02)00447-3

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  2 in total

Review 1.  Challenges in pulmonary fibrosis. 2: Bronchiolocentric fibrosis.

Authors:  Jean-François Cordier
Journal:  Thorax       Date:  2007-07       Impact factor: 9.139

2.  Retransplantation Outcomes at a Large Lung Transplantation Program.

Authors:  Dewei Ren; Thomas S Kaleekal; Edward A Graviss; Duc T Nguyen; Neeraj Sinha; Amad Goodarzi; Isioma Agboli; Erik E Suarez; Matthias Loebe; Scott A Scheinin; Brian A Bruckner
Journal:  Transplant Direct       Date:  2018-10-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.